89 related articles for article (PubMed ID: 11535970)
1. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
2. Neltenexine tablets in smoking and non-smoking patients with COPD. A double-blind, randomised, controlled study versus placebo.
Cattaneo C
Minerva Med; 2001 Aug; 92(4):277-84. PubMed ID: 11535971
[TBL] [Abstract][Full Text] [Related]
3. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
[TBL] [Abstract][Full Text] [Related]
4. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
Medici TC; Shang H; Grosgurin P; Berg P; Achermann R; Wehrli R
Bull Eur Physiopathol Respir; 1985; 21(6):477-83. PubMed ID: 3907738
[TBL] [Abstract][Full Text] [Related]
5. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
6. Action of neltenexine on anion secretion in human airway epithelia.
Niisato N; Hasegawa I; Tokuda S; Taruno A; Nakajima K; Miyazaki H; Iwasaki Y; Marunaka Y
Biochem Biophys Res Commun; 2007 May; 356(4):1050-5. PubMed ID: 17400191
[TBL] [Abstract][Full Text] [Related]
7. [Mucolytic agents. Polycentric study of a carbocysteine-sobrerol combination].
Gramiccioni E; Pamparana F; Messa A
Arch Monaldi Mal Torace; 1989; 44(4-6):791-3. PubMed ID: 2577796
[No Abstract] [Full Text] [Related]
8. [A controlled study on the action of a new formulation of ambroxol in asthmatiform bronchitis in children].
Baldini G; Gucci M; Tarò D; Memmini C
Minerva Pediatr; 1989 Feb; 41(2):91-5. PubMed ID: 2661989
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
[TBL] [Abstract][Full Text] [Related]
10. Intravenous aminophylline in patients admitted to hospital with non-acidotic exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial.
Duffy N; Walker P; Diamantea F; Calverley PM; Davies L
Thorax; 2005 Sep; 60(9):713-7. PubMed ID: 15939732
[TBL] [Abstract][Full Text] [Related]
11. Plant-based formulation in the management of chronic obstructive pulmonary disease: a randomized double-blind study.
Murali PM; Rajasekaran S; Paramesh P; Krishnarajasekar OR; Vasudevan S; Nalini K; Lakshmisubramanian S; Deivanayagam CN
Respir Med; 2006 Jan; 100(1):39-45. PubMed ID: 15905081
[TBL] [Abstract][Full Text] [Related]
12. Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
Braga PC; Allegra L; Bossi R; Scuri R; Castiglioni CL; Romandini S
Int J Clin Pharmacol Res; 1987; 7(5):381-400. PubMed ID: 3312046
[TBL] [Abstract][Full Text] [Related]
13. [Sobrerol as expectorant in patients with stable chronic respiratory tract infections. A controlled study].
Shang H; Grosgurin P; Medici TC
Schweiz Med Wochenschr; 1982 Dec; 112(50):1846-8. PubMed ID: 6760390
[TBL] [Abstract][Full Text] [Related]
14. Neltenexine: morphological investigation of protection against elastase-induced emphysema in rats.
Braga PC; Piatti G; Limoli A; Dal Sasso M; Maci S
Drugs Exp Clin Res; 1995; 21(2):51-7. PubMed ID: 7555609
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis].
Michnar M; Milanowski J
Pneumonol Alergol Pol; 1996; 64 Suppl 1():90-6. PubMed ID: 9190245
[TBL] [Abstract][Full Text] [Related]
16. Antiinflammatory properties of ambroxol.
Beeh KM; Beier J; Esperester A; Paul LD
Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
[TBL] [Abstract][Full Text] [Related]
17. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
18. Influence of mucolytic therapy on respiratory mechanics in patients with chronic obstructive pulmonary disease.
Schreiber J; Bohnsteen B; Rosahl W
Eur J Med Res; 2002 Mar; 7(3):98-102. PubMed ID: 11953279
[TBL] [Abstract][Full Text] [Related]
19. Open-label study of mirtazapine orally disintegrating tablets in depressed patients in the nursing home.
Roose SP; Nelson JC; Salzman C; Hollander SB; Rodrigues H;
Curr Med Res Opin; 2003; 19(8):737-46. PubMed ID: 14687445
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
